Abstract WMP15: Do Changes in Blood Brain Barrier Permeability Mediate the Association Between White Matter Hyperintensities and Post-Stroke Clinical Outcome?

Derrick Okine,Kyle Kern,Marco Egle,Marie L Luby,Lawrence Latour,Rebecca F Gottesman
DOI: https://doi.org/10.1161/str.55.suppl_1.wmp15
IF: 10.17
2024-02-01
Stroke
Abstract:Introduction: White matter hyperintensities (WMH) are associated with worse clinical outcomes after stroke. Our objective was to test whether blood brain barrier (BBB) permeability mediates the association between WMH and clinical outcome. Methods: In acute ischemic stroke patients who received tPA but not EVT, we quantified WMH volume on baseline FLAIR MRI scans using a deep learning algorithm and calculated WMH fraction (WMH volume/total intracranial volume). Hyperintense acute reperfusion injury marker (HARM) was evaluated for presence and severity at 24 hours on post-gadolinium FLAIR. Using logistic regression, we tested the associations between WMH fraction, presence and severity of HARM, and clinical outcomes. Finally, we used structural equation models to evaluate whether severe HARM mediated the relationship between WMH fraction and clinical outcomes including early neurological improvement (ENI), hemorrhagic transformation (HT), discharge NIHSS (dNIHSS), and 90-day modified Rankin Scale (mRS)). Results: Of 264 patients included in this study, (mean age 68 years, 44% female) 26% had severe HARM at 24 hours post-stroke and 25% had any HT (<5% with PH2). WMH fraction was associated with a higher risk of severe HARM (OR: 1.35, 95% CI: 1.03-1.78) after adjusting for demographics, vascular risk factors, plus NIHSS and infarct volume. WMH fraction was associated with dNIHSS, HT, and 90-day mRS in minimally adjusted models. In a mediation analysis, severe HARM explained a significant portion of the associations between WMH fraction and dNIHSS (35% mediation), 90-day mRS (28% mediation), or HT (40% mediation), each, in our demographics-adjusted models. Conclusions: Severe HARM partially mediates a significant portion of WMH’s effects on post-stroke clinical outcomes. Future studies should evaluate the mechanism behind this association and how the longitudinal effects of WMH on the BBB may be prevented.
peripheral vascular disease,clinical neurology
What problem does this paper attempt to address?